Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Astellas Pharma Inc (ALPMY)

Astellas Pharma Inc (ALPMY)
9.5550 -0.0950 (-0.98%) 14:27 ET [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
9.5400
Day High
9.9600
Open 9.7550
Previous Close 9.6500 9.6500
Volume 72,492 72,492
Avg Vol 310,126 310,126
Stochastic %K 77.79% 77.79%
Weighted Alpha -5.03 -5.03
5-Day Change +0.2800 (+3.02%) +0.2800 (+3.02%)
52-Week Range 8.3700 - 13.1400 8.3700 - 13.1400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 17,463,218
  • Shares Outstanding, K 1,809,660
  • Annual Sales, $ 10,620 M
  • Annual Income, $ 113,000 K
  • EBIT $ 548 M
  • EBITDA $ 1,869 M
  • 60-Month Beta 0.31
  • Price/Sales 1.42
  • Price/Cash Flow 8.15
  • Price/Book 1.73
  • Price/Earnings ttm 12.08
  • Earnings Per Share ttm 0.78
  • Most Recent Earnings $0.30 on 02/04/25
  • Next Earnings Date 04/24/25 [--]
  • Annual Dividend & Yield 0.17 (1.73%)
  • Most Recent Dividend 0.167 on 09/28/24
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.11
  • Growth Rate Est. (year over year) +908,081.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.3700 +14.22%
on 04/10/25
Period Open: 9.9900
10.0999 -5.35%
on 03/24/25
-0.4300 (-4.30%)
since 03/21/25
3-Month
8.3700 +14.22%
on 04/10/25
Period Open: 9.4400
10.1300 -5.63%
on 01/30/25
+0.1200 (+1.27%)
since 01/23/25
52-Week
8.3700 +14.22%
on 04/10/25
Period Open: 9.4900
13.1400 -27.25%
on 08/29/24
+0.0700 (+0.74%)
since 04/23/24

Most Recent Stories

More News
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst

It has been a rotten year for Apellis Pharmaceuticals stock, but better times could be ahead.

BAC : 38.81 (+1.28%)
ALPMY : 9.5550 (-0.98%)
APLS : 17.73 (+2.07%)
Here Are the 3 George Soros Stocks Most Likely to Turn $200,000 Into $1 Million Over the Next 20 Years

The multibillionaire's portfolio features some moneymaking ideas.

MSFT : 375.80 (+2.45%)
GOOG : 157.66 (+2.44%)
GOOGL : 155.24 (+2.49%)
ALPMY : 9.5550 (-0.98%)
AMZN : 181.60 (+4.86%)
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

XPH : 39.28 (+0.95%)
XLV : 135.29 (+0.17%)
HZNP : 116.30 (+0.04%)
NVO : 61.19 (+2.14%)
ALPMY : 9.5550 (-0.98%)
JNJ : 154.53 (-2.04%)
MRK : 78.50 (-0.60%)
LLY : 825.59 (-0.24%)
NVS : 109.91 (-1.35%)
AMGN : 276.55 (-0.66%)
BMY : 48.04 (-3.57%)
Why Shares of Annexon Are Plummeting Thursday

Mixed trial results on a geographic atrophy eye drug led investors to sell the biotech stock.

ALPMY : 9.5550 (-0.98%)
ISEE : 39.95 (+0.38%)
APLS : 17.73 (+2.07%)
ANNX : 1.8700 (+6.25%)
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today

These three biotech stocks were on the volatile side today.

TGTX : 39.61 (+4.26%)
VKTX : 26.06 (+2.28%)
ALPMY : 9.5550 (-0.98%)
APLS : 17.73 (+2.07%)
ISEE : 39.95 (+0.38%)
Pfizer buys Seagen for $43B, boosts access to cancer drugs

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue

ALPMY : 9.5550 (-0.98%)
$SPX : 5,384.02 (+1.82%)
$DOWI : 39,646.16 (+1.17%)
$IUXX : 18,765.02 (+2.67%)
PFE : 22.34 (-0.84%)
Got $1,000? Here's a Dirt-Cheap Big Pharma Stock to Buy

Pfizer should remain a pharma powerhouse long after the COVID-19 pandemic comes to an end.

ALPMY : 9.5550 (-0.98%)
JNJ : 154.53 (-2.04%)
PFE : 22.34 (-0.84%)
BNTX : 114.23 (+9.12%)
BMY : 48.04 (-3.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment...

See More

Key Turning Points

3rd Resistance Point 10.4955
2nd Resistance Point 10.2144
1st Resistance Point 9.9322
Last Price 9.5550
1st Support Level 9.3689
2nd Support Level 9.0878
3rd Support Level 8.8056

See More

52-Week High 13.1400
Fibonacci 61.8% 11.3179
Fibonacci 50% 10.7550
Fibonacci 38.2% 10.1921
Last Price 9.5550
52-Week Low 8.3700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective